These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11434154)

  • 1. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
    Cross J; Wedekind CA
    Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
    [No Abstract]   [Full Text] [Related]  

  • 2. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
    Kaji M
    Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiviral agents for influenza].
    Mitamura K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():798-803. PubMed ID: 12722319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Zanamivir, oseltamivir].
    Kashiwagi S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():445-7. PubMed ID: 15658359
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 7. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiinfluenza-drugs and the standard of the use].
    Matsumoto K
    Nihon Rinsho; 2000 Nov; 58(11):2283-7. PubMed ID: 11225318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Criteria for the use of anti-influenza agents].
    Kashiwagi S
    Nihon Rinsho; 2003 Nov; 61(11):1963-6. PubMed ID: 14619439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
    Hurt AC; Barr IG; Hartel G; Hampson AW
    Antiviral Res; 2004 Apr; 62(1):37-45. PubMed ID: 15026200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitors for treatment of influenza.
    Ebell MH
    Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
    [No Abstract]   [Full Text] [Related]  

  • 12. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
    Mungall BA; Xu X; Klimov A
    Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Critical review of anti-influenza drugs].
    van Loon FP; Voordouw AC; Simonian S; Koopmans PP
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):165-7. PubMed ID: 10668542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O; Kessler N; Lina B
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
    Uhnoo I; Linde A
    Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drugs prophylaxis and treatment of influenza.
    Med Lett Drugs Ther; 2006 Oct; 48(1246):87-8. PubMed ID: 17051136
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
    Lange W; Vogel GE
    MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
    Hurt AC; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.